EHRA Premium Access

Do we follow the recommendation of anticoagulation withdrawal after electrical cardioversion, in patients with atrial fibrillation?

Congress Session

About the speaker

Doctor Maria Vidal Burdeus

University Hospital Vall d'Hebron, Barcelona (Spain)
0 follower

39 more presentations in this session

Determinants of progression of persistent to permanent atrial fibrillation - data from the RACE 3 study

Speaker: Doctor R. De With (Groningen, NL)

Thumbnail

The electrocardiographic and echocardiographic factors affecting infarct volume in acute ischaemic stroke

Speaker: Doctor D. Ranganathan (Dublin, IE)

Thumbnail

Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Cryptogenic stroke is associated with atrial fibrosis similar to atrial fibrillation

Speaker: Associate Professor N. Akoum (Seattle, US)

Thumbnail

Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Access the full session

Poster session 3 - Atrial fibrillation - Clinical

Speakers: Doctor M. Vidal Burdeus, Doctor R. De With, Doctor D. Ranganathan, Doctor M. Proietti, Associate Professor N. Akoum...
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk